Member Info for B2HS2L

EXMEX -
They have stated this:
From 25.01 RNS
"The Company intends to announce its 2021 audited full year results in the week commencing 25 April 2022"

So I think you pinned the tail on the Donkey there ha ha!

hamster18 - who else?
Guillermo Raimondo

Good post Hurst10, -
Later info on Project Orbis here:
https://www.gov.uk/guidance/guidance-on-project-orbis#products-eligible-for-project-orbis

Yes indeed Gazman.

https://sciquip.co.uk/mygo-pro-esr-qpcr-instrument3-1.html

MyGo Pro qPCR Instrument - was £9,495.00 now £8,545.50

Looks like sciquip are benefitting from a large order discounts at these prices though.

09:52

Proactive Investor interview with David Allmond, 25.01.2022
"...but the clearest opportunity for us is to leverage our CE marked products across the European economic area, so a huge area for which we already have regulatory coverage."
IMO DA isn't interested in Novacyt US Inc.

Is that you talking rubbish?

Poidster -
There are a lot fewer Ukrainian soldiers than Russian.
Losing 10 Ukrainian fighters is the equivalent of losing 100 Russian.
It's a war of attrition, and eventually, no matter how many weapons the West gives Ukraine,
there will soon be nobody left to use them.
There are only so many staff in the NHS.
When you take out those who are looking after sick relatives and too ill to work there will be fewer.
But the govnt wants staff who are fit for work to deal with wave after wave of hospitalisations, placing the worst affected on ventilators etc.
The govnt don't seem to realise that there is insufficient time for staff to rest and recuperate between waves.
It will soon become easier for individual hospitals to become overwhelmed IMO, and part of that scenario will have been caused by Sajid and his team not understanding you cannot keep asking for more effort from a dwindling population of NHS staff.
Time to reinstate Covid restrictions, because even Joe public will realise that has to happen when hospitals are overwhelmed.

Hi Poidster -

From 25.01.2022 RNS:
Operational highlights
"Inclusion in National Framework Agreement, resulting in a new £4.7m contract with the DHSC for the supply of PROmate® COVID-19 tests to the NHS"

From 27.09.2021 RNS:
"Inclusion in PHE National Framework Agreement, resulting in a new contract with the DHSC for the supply of PROmate® COVID-19 tests to the NHS"
+++

If we are supplying Promate under the National Framework Agreement, is it likely that we may be able to supply CO-Prep liquid handling cabinets with which to streamline and create more accurate sample analysis, under this framework, or do you feel CO-Prep cannot be supplied this way?

Kevinl1977 -
This morning at 10:37 you asked TommyD_19 the source of the following text:

"conditional upon a successful Phase 3 readout, the Company is preparing for the filing of an Emergency Use Authorisation (EUA) in the US for patients requiring hospitalisation due to COVID-19"

This RNS contains that text:
Synairgen completes Phase III recruitment
Thu, 11th Nov 2021.

++++

Thank you Tommy for earlier providing the very interesting link which I reproduce here:
https://www.bmj.com/content/357/bmj.j1680

HillSeeker, -
The purchase I had expected was from Guillermo Raimondo.
GLALTH

Doc83 - Ditto!

If we assumed that ACTIV-2 and Synairgen create a new clinical trial design for SNG001, there will be a period of time for the new design to be accepted by NIAID and NIH, and that isn't a sure thing.
But if those things came to pass, the value of a Synairgen share would not be 20p.
Polygon would be in a stronger position to sell there shares to a (more interested) third party.

We need to take things easy as there are an awful lot of 'IF's', but this scenario is doable.

And that is without visibility of deep dive and ACTIV- 2 trial data.

Globally there will be much more PCR testing necessary, because Omicron BA2 is creating the need country by country.
This should be happening from now onwards.
Remember each new variant is more easily spread than the last, and some variants are more lethal than the preceeding one.

Aether -
As a result, lead investigators from ACTIV-2 and Synairgen are in ongoing discussions...

For those who seem to have lost all hope of recouping anything from the financial pile of debris that used to be near the centre of our portfolio, and now resembles the physical devastation of some Ukranian cities,
I take support from the FACT that ACTIV-2 investigators are still interested in a new clinical trial design for SNG001, - which isn't guaranteed, - but they would not be talking if there was no interest.
They know any new ACTIV-2 study would be at Uncle Sam's expense, and they are still interested.
Polygons actions in picking up more shares might now recommence now the price is lower.

Thanks Pboo.
Best case then = 10 * 215 = 2150 BOPD currently.

Nice little earner

How many barrels of oil in one road tanker please. XXX
Current permission for 10 road tanker visits to site per day makes the site capacity 10 * XXX barrels of oil per day.
Can anyone supply XXX please.

From todays RNS:
"Due to these changes in the pandemic, a new clinical trial design is needed to evaluate the efficacy of SNG001 against COVID-19.
As a result, lead investigators from ACTIV-2 and Synairgen are in ongoing discussions to try to identify an appropriate clinical trial to continue the evaluation of SNG001."
+++
RM commented:
"Even with improved standard of care, there remains a critical need to prevent progression to severe disease and death. As such, we are actively seeking inclusion in platform trials for hospitalised patients and are working closely with the NIH to also find a suitable trial for SNG001 in home-based patients."

These are the most positive parts for me, but of course there are no timescales.
Anyone having knowledge of how long these 'fixes' might take to come to fruition - please advise.
<3 months?
> 6 months?
Something in between?

My local gin palace uses sea weed as an ingredient to distil competition winning Gin.
After imbibing said elixir, there's no chance of anyone standing on one leg in a bus shelter - Tuesday or not.

I think this is likely -
"the company think the physical launch of co prep isn't material enough to warrant an RNS"
because there are a number of more important subjects that must be RNS'd that will be ready to notify soon.
In comparison with these subjects, CO-Prep launch is not material enough.
++++
- but it probably would be if it were the case that Novacyt released the number of pre-launch orders that have been taken, and what these were worth.

That wouldn't be an 'R&D update' tomorrow, - complete with CO-Prep market launch details?
That would buoy the sp.
We must be due one, else everything comes at end of April :(